4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide
C29H39N5O5 — CID 10875187
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide
4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide (PubChem CID 10875187) has the molecular formula C29H39N5O5 and a molecular weight of 537.66 g/mol. Its IUPAC name is 4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide.
Molecular Properties
| Compound Name | 4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide |
|---|---|
| PubChem CID | 10875187 |
| Molecular Formula | C29H39N5O5 |
| Molecular Weight | 537.66 g/mol |
| Exact Mass | 537.30 |
| IUPAC Name | 4-[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]-N-(4-tert-butylphenyl)piperazine-1-carboxamide |
| SMILES | COCCOc1cc2ncnc(N3CCN(C(=O)Nc4ccc(C(C)(C)C)cc4)CC3)c2cc1OCCOC |
| InChI | InChI=1S/C29H39N5O5/c1-29(2,3)21-6-8-22(9-7-21)32-28(35)34-12-10-33(11-13-34)27-23-18-25(38-16-14-36-4)26(39-17-15-37-5)19-24(23)30-20-31-27/h6-9,18-20H,10-17H2,1-5H3,(H,32,35) |
| InChIKey | VUPVZTSBVJMKOY-UHFFFAOYSA-N |
| XLogP | 4.33 |
| TPSA | 98.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 537.66 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 10875187 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.